What is Hyprevention?
Hyprevention Inc. is at the forefront of developing advanced medical technologies, with a core focus on STRUTPLASTY, a groundbreaking method for reinforcing bones compromised by osteoporosis or cancer. The company's product portfolio includes sophisticated implantable devices such as V-STRUT and Y-STRUT, engineered to effectively treat existing fractures and proactively prevent future bone breaks. By integrating in-house research with external clinical expertise, Hyprevention is dedicated to creating patient-centric solutions for healthcare professionals and institutions managing bone-related conditions.
How much funding has Hyprevention raised?
Hyprevention has raised a total of $823K across 1 funding round:
Unspecified
$823K
Unspecified (2015): $823K, investors not publicly disclosed
What's next for Hyprevention?
The substantial enterprise-level funding signifies a pivotal moment for Hyprevention, positioning the company for significant scaling and market penetration. This capital infusion is expected to accelerate the development and commercialization of their STRUTPLASTY technology, potentially expanding their reach within the orthopedic and oncology markets. Strategic investments of this magnitude typically fuel further research and development, enhance manufacturing capabilities, and bolster sales and marketing efforts to establish a dominant presence in the medical device sector.
See full Hyprevention company page
